Identification of HER2-Positive Metastases in Patients with HER2-Negative Primary Breast Cancer by Using HER2-targeted 89Zr-Pertuzumab PET/CT
about
Identification of HER2-Positive Metastases in Patients with HER2-Negative Primary Breast Cancer by Using HER2-targeted 89Zr-Pertuzumab PET/CT
description
scientific article published on 09 June 2020
@en
wetenschappelijk artikel
@nl
name
Identification of HER2-Positiv ...... argeted 89Zr-Pertuzumab PET/CT
@en
Identification of HER2-Positiv ...... argeted 89Zr-Pertuzumab PET/CT
@nl
type
label
Identification of HER2-Positiv ...... argeted 89Zr-Pertuzumab PET/CT
@en
Identification of HER2-Positiv ...... argeted 89Zr-Pertuzumab PET/CT
@nl
prefLabel
Identification of HER2-Positiv ...... argeted 89Zr-Pertuzumab PET/CT
@en
Identification of HER2-Positiv ...... argeted 89Zr-Pertuzumab PET/CT
@nl
P2093
P50
P1433
P1476
Identification of HER2-Positiv ...... argeted 89Zr-Pertuzumab PET/CT
@en
P2093
Dara S Ross
David M Hyman
Komal Jhaveri
Sarat Chandarlapaty
Serge K Lyashchenko
P304
P356
10.1148/RADIOL.2020192828
P50
P577
2020-06-09T00:00:00Z